The results showed that FGF8 treatment obviously increased the YAP1 mRNA levels in all three CRC cell lines, and PD173074 can inhibit this accumulation, suggesting FGF8 can enhance the transcription of YAP1. The gene discussed is FGF8; the disease is colorectal carcinoma.